Scilex (SCLX) Competitors $0.45 +0.01 (+1.64%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SCLX vs. CYRX, PROC, NGNE, BTMD, DSGN, VYGR, CTNM, SLRN, KMDA, and TRVIShould you be buying Scilex stock or one of its competitors? The main competitors of Scilex include Cryoport (CYRX), Procaps Group (PROC), Neurogene (NGNE), biote (BTMD), Design Therapeutics (DSGN), Voyager Therapeutics (VYGR), Contineum Therapeutics (CTNM), Acelyrin (SLRN), Kamada (KMDA), and Trevi Therapeutics (TRVI). These companies are all part of the "pharmaceutical products" industry. Scilex vs. Cryoport Procaps Group Neurogene biote Design Therapeutics Voyager Therapeutics Contineum Therapeutics Acelyrin Kamada Trevi Therapeutics Cryoport (NASDAQ:CYRX) and Scilex (NASDAQ:SCLX) are both small-cap transportation companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability. Does the MarketBeat Community favor CYRX or SCLX? Cryoport received 232 more outperform votes than Scilex when rated by MarketBeat users. However, 100.00% of users gave Scilex an outperform vote while only 65.05% of users gave Cryoport an outperform vote. CompanyUnderperformOutperformCryoportOutperform Votes24265.05% Underperform Votes13034.95% ScilexOutperform Votes10100.00% Underperform VotesNo Votes Which has better earnings & valuation, CYRX or SCLX? Cryoport has higher revenue and earnings than Scilex. Cryoport is trading at a lower price-to-earnings ratio than Scilex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCryoport$226.11M1.72-$99.59M-$3.38-2.33Scilex$50.83M1.69-$114.33M-$1.43-0.31 Is CYRX or SCLX more profitable? Cryoport has a net margin of -70.08% compared to Scilex's net margin of -233.88%. Scilex's return on equity of 0.00% beat Cryoport's return on equity.Company Net Margins Return on Equity Return on Assets Cryoport-70.08% -13.35% -6.43% Scilex -233.88%N/A -111.82% Which has more volatility & risk, CYRX or SCLX? Cryoport has a beta of 1.62, suggesting that its share price is 62% more volatile than the S&P 500. Comparatively, Scilex has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Does the media refer more to CYRX or SCLX? In the previous week, Scilex had 2 more articles in the media than Cryoport. MarketBeat recorded 5 mentions for Scilex and 3 mentions for Cryoport. Cryoport's average media sentiment score of 0.97 beat Scilex's score of 0.69 indicating that Cryoport is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cryoport 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Scilex 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate CYRX or SCLX? Cryoport presently has a consensus target price of $12.29, suggesting a potential upside of 56.31%. Scilex has a consensus target price of $11.33, suggesting a potential upside of 2,432.59%. Given Scilex's stronger consensus rating and higher probable upside, analysts clearly believe Scilex is more favorable than Cryoport.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cryoport 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57Scilex 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders hold more shares of CYRX or SCLX? 92.9% of Cryoport shares are owned by institutional investors. Comparatively, 69.7% of Scilex shares are owned by institutional investors. 10.1% of Cryoport shares are owned by insiders. Comparatively, 8.7% of Scilex shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryCryoport beats Scilex on 11 of the 18 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCLX vs. The Competition Export to ExcelMetricScilexBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$85.83M$2.94B$5.12B$9.07BDividend YieldN/A1.90%4.91%4.22%P/E Ratio-0.3146.7391.3417.19Price / Sales1.69411.851,116.59116.80Price / CashN/A182.1042.6437.86Price / Book-0.413.894.794.78Net Income-$114.33M-$42.21M$120.07M$225.60M7 Day Performance-11.82%-2.14%-1.89%-1.24%1 Month Performance-18.86%4.21%11.45%3.36%1 Year Performance-66.35%18.40%30.61%16.58% Scilex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCLXScilex3.1746 of 5 stars$0.45+1.6%$11.33+2,432.6%-65.6%$85.83M$50.83M-0.3180CYRXCryoport3.0208 of 5 stars$7.58-1.4%$12.50+64.9%-49.8%$374.69M$226.11M-2.321,170Analyst ForecastGap DownPROCProcaps Group0.8826 of 5 stars$3.23+34.0%N/A-20.3%$364.41M$414.10M5.105,500News CoverageHigh Trading VolumeNGNENeurogene3.7408 of 5 stars$24.22+3.0%$60.83+151.2%N/A$359.79M$925,000.000.0090BTMDbiote3.0893 of 5 stars$6.60+3.6%$9.11+38.0%+20.8%$358.62M$193.06M24.77194Positive NewsGap UpDSGNDesign Therapeutics0.9221 of 5 stars$6.29+12.3%$7.00+11.3%+143.2%$356.15MN/A-7.1840News CoveragePositive NewsVYGRVoyager Therapeutics4.6114 of 5 stars$6.49+3.5%$17.00+161.9%-27.6%$354.55M$250.01M8.83100CTNMContineum Therapeutics1.9558 of 5 stars$13.65-2.7%$29.25+114.3%N/A$351.90M$50M0.0031News CoverageSLRNAcelyrin2.7884 of 5 stars$3.38+4.6%$11.75+247.6%-55.8%$339.12MN/A-1.31135KMDAKamada3.8909 of 5 stars$5.84-0.5%$14.50+148.3%-1.2%$335.68M$158.38M20.96360Positive NewsTRVITrevi Therapeutics3.0363 of 5 stars$4.34+4.1%$9.31+114.6%+214.0%$333.62MN/A-10.2020Gap DownHigh Trading Volume Related Companies and Tools Related Companies CYRX Alternatives PROC Alternatives NGNE Alternatives BTMD Alternatives DSGN Alternatives VYGR Alternatives CTNM Alternatives SLRN Alternatives KMDA Alternatives TRVI Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SCLX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scilex Holding Please log in to your account or sign up in order to add this asset to your watchlist. Share Scilex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SCLX Stock Alerts